Cargando…

Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia

A new study published by the journal Aging & Disease reported that intravenous administration of clinical-grade human mesenchymal stem cells (MSCs) into patients with coronavirus disease 2019 (COVID-19) resulted in improved functional outcomes (Leng et al., Aging Dis, 11:216-228, 2020). This stu...

Descripción completa

Detalles Bibliográficos
Autor principal: Shetty, Ashok K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069463/
https://www.ncbi.nlm.nih.gov/pubmed/32257554
http://dx.doi.org/10.14336/AD.2020.0301

Ejemplares similares